114 related articles for article (PubMed ID: 1364936)
1. Enteric-coated and plain naproxen tablets in osteoarthritis; tolerability and efficacy.
Lehn OF; Jensen ON; Andersen LA; Christensen KA; Solheim L; Barslev J; Mjølstad W; Wiig G; Ibfelt HH; Kjønniksen T
Eur J Rheumatol Inflamm; 1992; 12(2):31-6. PubMed ID: 1364936
[TBL] [Abstract][Full Text] [Related]
2. Morning stiffness and nightime pain in ankylosing spondylitis. A comparison between enteric-coated and plain naproxen tablets.
Johnsen V; Brun JG; Fjeld E; Hansen K; Sydnes OA; Ugstad MB
Eur J Rheumatol Inflamm; 1992; 12(2):37-42. PubMed ID: 1364937
[TBL] [Abstract][Full Text] [Related]
3. A double blind study comparing the efficacy and safety of enteric coated naproxen to naproxen in the management of NSAID intolerant patients with rheumatoid arthritis and osteoarthritis. Naproxen EC Study Group.
Caldwell JR; Roth SH
J Rheumatol; 1994 Apr; 21(4):689-95. PubMed ID: 8035394
[TBL] [Abstract][Full Text] [Related]
4. Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulations.
Huskisson EC; Bernstein RM; Coppock JS; Davies PG; Doyle DV; Platt PR; Scott DL; Witherington RH; Wojtulewski JA
Eur J Rheumatol Inflamm; 1992; 12(2):27-30. PubMed ID: 1364935
[TBL] [Abstract][Full Text] [Related]
5. Naproxen-associated gastroduodenal toxicity: enteric coated granules versus plain tablets.
Aabakken L; Ugstad M; Gamst ON; Winther R; Osnes M
Eur J Rheumatol Inflamm; 1992; 12(2):43-8. PubMed ID: 1364939
[TBL] [Abstract][Full Text] [Related]
6. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic findings in the stomach and duodenum after treatment with enteric-coated and plain naproxen tablets in healthy subjects.
Oddsson E; Gudjonsson H; Thjodleifsson B
Scand J Gastroenterol; 1990 Mar; 25(3):231-4. PubMed ID: 2181621
[TBL] [Abstract][Full Text] [Related]
8. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group.
Altman RD; Moskowitz R
J Rheumatol; 1998 Nov; 25(11):2203-12. PubMed ID: 9818665
[TBL] [Abstract][Full Text] [Related]
9. Double-blind study comparing the long-term efficacy of the COX-2 inhibitor nimesulide and naproxen in patients with osteoarthritis.
Kriegel W; Korff KJ; Ehrlich JC; Lehnhardt K; Macciocchi A; Moresino C; Pawlowski C
Int J Clin Pract; 2001 Oct; 55(8):510-4. PubMed ID: 11695069
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis: a double-blind comparison with standard naproxen followed by an open-label trial.
Bellamy N; Beaulieu A; Bombardier C; Huang S; Kraag G; Ménard HA; Russell AS; Tannenbaum H; Willans M; Campbell J
Curr Med Res Opin; 1992; 12(10):640-51. PubMed ID: 1633722
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and tolerability of enteric and non-enteric coated naproxen tablets: a double-blind study in patients with osteoarthritis.
Khong TK; Downing ME; Ellis R; Patchett I; Trayner J; Miller AJ
Curr Med Res Opin; 1991; 12(8):540-6. PubMed ID: 1764957
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
Daniels S; Robbins J; West CR; Nemeth MA
Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
[TBL] [Abstract][Full Text] [Related]
13. Naproxen vs. aspirin in osteoarthritis of the hip and knee.
Melton JW; Lussier A; Ward JR; Neustadt D; Multz C
J Rheumatol; 1978; 5(3):338-46. PubMed ID: 372525
[TBL] [Abstract][Full Text] [Related]
14. Gastroscopic findings after treatment with enteric-coated and plain naproxen tablets in healthy subjects.
Trondstad RI; Aadland E; Holler T; Olaussen B
Scand J Gastroenterol; 1985 Mar; 20(2):239-42. PubMed ID: 3887555
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.
Kidd B; Frenzel W
J Rheumatol; 1996 Sep; 23(9):1605-11. PubMed ID: 8877932
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
18. Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study.
Schnitzer TJ; Kamin M; Olson WH
Arthritis Rheum; 1999 Jul; 42(7):1370-7. PubMed ID: 10403264
[TBL] [Abstract][Full Text] [Related]
19. Double-blind study of suprofen vs naproxen in the treatment of osteoarthritic pain.
Fellmann N; Stocker H; Reuteler H
Eur J Rheumatol Inflamm; 1983; 6(2):216-21. PubMed ID: 6201367
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic equivalence of diclofenac sustained-released 75 mg tablets and diclofenac enteric-coated 50 mg tablets in the treatment of painful osteoarthritis.
Le Loët X; Dreiser RL; Le Gros V; Febvre N
Int J Clin Pract; 1997 Sep; 51(6):389-93. PubMed ID: 9489070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
